Smart use of off-patent medicines will be critical to rebuild healthcare systems successfully post-Covid

7 October 2021

Baton passes from Christoph Stoller to Rebecca Guntern as President of Medicines for Europe

1 October 2021

Rebecca Guntern (Sandoz) today begins an interim term as President […]

HERA must address outstanding weaknesses in EU pharma framework to be successful

16 September 2021

Medicines For Europe strongly supports the EU’s drive to learn from COVID-19 […]

EU must take the lead to ensure security of supply for medicines

16 June 2021

Legislative reforms aligned with current off-patent market conditions are the […]

Open borders that prioritise essential goods key to medicines supply in Europe

2 June 2021

EU Industrial strategy should be key to improving medicines supply chains

17 May 2021

The newly launched update of the industrial strategy aims to […]

“Off patent medicines essential for a fairer, healthier, and sustainable Europe” says President Christoph Stoller

30 April 2021

Christoph Stoller will speak at 3A CONFERENCE – Availability, Accessibility, […]

EU industrial policy can dramatically improve medicines manufacturing resilience and security of supply

17 March 2021

New report reveals need for pricing and reimbursement and procurement reforms to ensure patient access and healthcare sustainability

1 March 2021

Smart policies will encourage more critical medicines manufacturing in Europe

26 February 2021